AbbVie Inc $55.20

up +0.24


22/8/2014 04:00 PM  |  NYSE : ABBV  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get ABBV Trend Analysis - it has outperformed the S&P 500 by 8%

Partner Headlines

  1. Biotech Leader Gilead Sciences Scores Sovaldi Win

    IBD
  2. Gilead Wins Sovaldi Dispute With Roche, U.K. Nod

    IBD
  3. 5 Companies That Have Moved Overseas For Lower Taxes

    Benzinga
  4. GW Pharma, Insys Face Off In Cannabis Drug Space

    IBD
  5. Markets Little Changed As Ukraine Uncertainty And Fears Persist

    Benzinga
  6. Walgreen Leads Sell-Off In 'Tax Inversion' Stocks

    IBD
  7. #PreMarket Primer: Wednesday, August 6: Sprint Prepares To Go It Alone

    Benzinga
  8. Walgreen Seen Rejecting Tax Inversion Amid Pressure

    IBD
  9. Walgreen Names New CFO Ahead of Possible Inversion

    IBD
  10. Amgen Cancer Drug Kyprolis Succeeds In Trial

    IBD
  11. Salix, Actavis Lead IBD 50 Drug Earnings This Week

    IBD
  12. US M&A Announced Deals Surpass $1 Trillion For 2014

    Benzinga
  13. Pharmacyclics Q2 Earnings Get Mixed Reception

    IBD
  14. The Stocks Already in Correction Mode

    FoxBusiness
  15. Markets Little Changed Ahead Of The Federal Reserve's Policy Decision

    Benzinga
  16. How Obama Could End Walgreen's Tax-Inversion Hopes

    IBD
  17. UPDATE: UBS Upgrades AbbVie

    Benzinga
  18. AbbVie Beats Earnings Views, Sees Slower Humira Gain

    IBD
  19. #PreMarket Primer: Thursday, July 24: Facebook Proves Its Worth

    Benzinga
  20. FT: 25 More Firms May Seek Tax Breaks Overseas

    FoxBusiness
  21. Benzinga's Weekend M&A Chatter

    Benzinga
  22. AbbVie Clinches Shire Deal

    IBD
  23. Investors Focus On Earnings Rather Than Geopolitical Tensions

    Benzinga
  24. Will Congress Scuttle the AbbVie-Shire Merger?

    FoxBusiness
  25. AbbVie Buys Shire For $54 Billion

    IBD
  26. Stocks Futures Up On Q2 Reports; Abbvie-Shire, Google Positive

    IBD
  27. Benzinga's Top #PreMarket Losers

    Benzinga
  28. AbbVie to Acquire Shire for £24.44 in Cash and 0.8960 New AbbVie Shares

    Benzinga
  29. Markets Sell-Off After Malaysian Airline Crash In Ukraine

    Benzinga
  30. Treasury Urges Halt to Tax Inversion M&A 'Abuse'

    IBD
  31. J&J Earnings Beat Estimates, But Guidance Mixed

    IBD
  32. Bank Of America Boosts AbbVie PT On Increased Likelihood Of Deal

    Benzinga
  33. Irish Stocks Come To Prominence As Taxes Stay Low

    IBD
  34. AbbVie Near $54 Bil Shire Buy

    IBD
  35. Mylan, AbbVie News Shows Tax Inversion Boom Continues

    IBD
  36. Dow Sets New Intraday High; Citigroup Impresses With Earnings

    Benzinga
  37. Stocks On Pace For Second Gain; Kandi Keeps Soaring

    IBD
  38. Mylan Buying Abbott Generics Unit, Moving Abroad

    IBD
  39. Can Investors Profit From Friday's Rumors? Depends Who You Ask

    Benzinga
  40. Benzinga's Top #PreMarket Losers

    Benzinga
  41. US Stock Futures Surge; All Eyes On Citigroup Results

    Benzinga
  42. Benzinga's Weekend M&A Chatter

    Benzinga
  43. Walgreen Tax Inversion: Masking A Weak Business?

    YCharts
  44. Markets Close Higher Ahead Of Busy Earnings Season

    Benzinga
  45. Shire Shares Volatile Surrounding Speculation And Confirmation Of AbbVie ...

    Benzinga
  46. Stocks Trade Around Flat Line; Harman Clears Buy Point

    IBD
  47. Senators Ask Gilead To Explain Sovaldi Pricing

    IBD
  48. Benzinga's M&A Chatter for Wednesday July 9, 2014

    Benzinga
  49. Stocks Rebound From 2 Day Drop As The Fed Confirms The End Of QE Is Near

    Benzinga
  50. Deutsche Bank Analyst Talks Up Biogen On CNBC; Stock Responds Slightly

    Benzinga
Trading Center